Immune-Stimulatory Dinucleotide at the 5′-End of Oligodeoxynucleotides Is Critical for TLR9-Mediated Immune Responses (original) (raw)

Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation

Paul J Payette

Immunology, 2004

Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity

Klaus Heeg

Immunology, 2008

Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications

2006

Immunomodulatory oligonucleotides containing a cytosine-phosphate-2′-deoxy-7-deazaguanosine motif as potent Toll-like receptor 9 agonists

Proceedings of the National Academy of Sciences, 2005

Oligodeoxyribonucleotide-Based Antagonists for Toll-Like Receptors 7 and 9

Journal of Medicinal Chemistry, 2009

Development of CpG-oligodeoxynucleotides for effective activation of rabbit TLR9 mediated immune responses

Ping-hui Tseng

PloS one, 2014

Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity

Arthur Krieg

Journal of Leukocyte Biology, 2004

Agonists of Toll-like Receptor 9 Containing Synthetic Dinucleotide Motifs

Journal of Medicinal Chemistry, 2007

Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction

Atie Suwarti

Biochemical and biophysical research communications, 2013

Synthesis and immunological activities of novel agonists of toll-like receptor 9

Ireneusz Nowak

Cellular Immunology, 2010

Guanine-Modified Inhibitory Oligonucleotides Efficiently Impair TLR7- and TLR9-Mediated Immune Responses of Human Immune Cells

Hermann Wagner

PLOS ONE, 2015

CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responses

Chiou-Hwa Cathy Yuh

Scientific reports, 2017

A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif

Proceedings of the National Academy of Sciences, 2003

Recent advances in the development of immunostimulatory oligonucleotides

Eugen Uhlmann

Non-CpG-Containing Antisense 2′-Methoxyethyl Oligonucleotides Activate a Proinflammatory Response Independent of Toll-Like Receptor 9 or Myeloid Differentiation Factor 88

Sebastien Burel

Journal of Pharmacology and Experimental Therapeutics, 2005

Impact of Secondary Structure of Toll-Like Receptor 9 Agonists on Interferon Alpha Induction

Antimicrobial Agents and Chemotherapy, 2008

Design of synthetic oligoribonucleotide-based agonists of Toll-like receptor 3 and their immune response profiles in vitro and in vivo

Organic & Biomolecular Chemistry, 2013

Toll-like Receptor 7 Selective Synthetic Oligoribonucleotide Agonists: Synthesis and Structure−Activity Relationship Studies

Fugang Zhu

Journal of Medicinal Chemistry, 2009

Ligand-induced conformational changes allosterically activate Toll-like receptor 9

anjali verma

Nature Immunology, 2007

Oligodeoxynucleotides Modifiers and PolyT Imidazoquinoline Immune Response TLR8 by a Combination of Cutting Edge: Activation of Murine

John Vasilakos

2010

Toll-Like Receptor 9-Independent Suppression of Skin Inflammation by Oligonucleotides

Andor Pivarcsi

Journal of Investigative Dermatology, 2007

Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9

Jeng-fan Lo

Comparative Immunology, Microbiology and Infectious Diseases, 2012

Divergent synthetic nucleotide motif recognition pattern: design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine induction profiles

Nucleic Acids Research, 2003

Synthetic oligoribonucleotides containing arabinonucleotides act as agonists of TLR7 and 8

daqing wang

Bioorganic & Medicinal Chemistry Letters, 2009

The Distinct and Cooperative Roles of Toll-Like Receptor 9 and Receptor for Advanced Glycation End Products in Modulating In Vivo Inflammatory Responses to Select CpG and Non-CpG Oligonucleotides

Suzanne Paz

Nucleic acid therapeutics, 2017

Modulating Toll-like Receptor 7 and 9 Responses as Therapy for Allergy and Autoimmunity

Petar Lenert

Current Allergy and Asthma Reports, 2011

High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9–TRIF pathway

Louis Boon

Nature Communications, 2013